| Filed On | Filing |
|---|---|
| 19 Oct 2026 |
8-K: Other Events
IRVINE, Calif., October 19, 2026 – SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditi... |
| 01 Oct 2026 |
8-K: Regulation FD Disclosure; Other Events
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 14 May 2026 | 10-Q |
| 14 May 2026 | 8-K: Results of Operations and Financial Condition |
| 26 Mar 2026 | 10-K |
| 26 Mar 2026 | 8-K: Results of Operations and Financial Condition |
| 09 Mar 2026 | 8-K: Other Events |
| 17 Feb 2026 | SCHEDULE 13G |
| 17 Feb 2026 | SCHEDULE 13D |
| 13 Feb 2026 | SCHEDULE 13D |
| 13 Feb 2026 | SCHEDULE 13G |
| 13 Feb 2026 | SCHEDULE 13D |
| 13 Feb 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 11 Feb 2026 |
Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others
Received 4,331,117 shares by conversion · Bought 3,690,000 shares ($59M) |
| 11 Feb 2026 |
Form 4/A: Nielsen Kirk G., Director
Converted 1,690,230 Series B Preferred Stock · Converted 548,067 Series C-1 Preferred Stock · Converted 548,067 Series C-2 Preferred Stock · 1 more |
| 11 Feb 2026 |
Form 4: Behbahani Ali, Director
Received 6,454,801 shares by conversion · Bought 937,500 shares ($15M) |
| 11 Feb 2026 |
Form 4: Florence Anthony A. Jr., 10% owner
Received 6,454,801 shares by conversion · Bought 937,500 shares ($15M) |
| 11 Feb 2026 |
Form 4: Baskett Forest, 10% owner
Received 6,454,801 shares by conversion · Bought 937,500 shares ($15M) |
Loading...
